223490-68-4

Basic information

• Product Name: methyl 3-(3-aminomethylphenyl)propanoate(HCl)
• Synonyms: methyl 3-(3-aminomethylphenyl)propanoate(HCl);methyl 3-(3-(aminomethyl)phenyl)propanoate hydrochloride
• CAS NO: 223490-68-4
• Molecular Formula: C₁₁H₁₅NO₂*ClH
• Molecular Weight: 229.7
• Mol File: 223490-68-4.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: methyl 3-(3-aminomethylphenyl)propanoate(HCl)(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 3-(3-aminomethylphenyl)propanoate(HCl)(223490-68-4)
• EPA Substance Registry System: methyl 3-(3-aminomethylphenyl)propanoate(HCl)(223490-68-4)

Safety Data

• Hazardous Substances Data: 223490-68-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 3-(3-aminomethylphenyl)propanoate(HCl) is used as a pharmaceutical intermediate for the synthesis of various drugs due to its valuable chemical structure and properties.
It is used as an active pharmaceutical ingredient for the production of medications for treating various conditions, leveraging its pharmacological properties.

Upstream product

• 79432-87-4 methyl m-bromocinnamate 
• 193151-10-9 3-(3-cyano-phenyl)-acrylic acid methyl ester 

Downstream Products

• 223491-73-4 3-{3-[(4-isobutyl-benzylamino)-methyl]-phenyl}-propionic acid methyl ester 
• 223491-41-6 3-(3-cyano-phenyl)-2-methyl-propionic acid methyl ester 
• 223491-67-6 3-(3-{[(2,3-Dihydro-benzofuran-5-ylmethyl)-methanesulfonyl-amino]-methyl}-phenyl)-propionic acid methyl ester 
• 223491-59-6 3-(3-{[(4-tert-butyl-benzyl)-(pyridine-2-sulfonyl)-amino]-methyl}-phenyl)-propionic acid methyl ester 
• 223491-76-7 3-(3-{[benzenesulfonyl-(4-isobutyl-benzyl)-amino]-methyl}-phenyl)-propionic acid methyl ester 
• 223491-44-9 2-Methyl-3-{3-[(4-pyrazol-1-yl-benzylamino)-methyl]-phenyl}-propionic acid methyl ester 
• 223492-59-9 3-(3-{[(4-tert-butyl-benzyl)-(thiazole-2-sulfonyl)-amino]-methyl}-phenyl)-propionic acid methyl ester 
• 223491-12-1 3-(3-{[(1-Methyl-1H-imidazole-4-sulfonyl)-(4-pyrazol-1-yl-benzyl)-amino]-methyl}-phenyl)-propionic acid methyl ester 
• 223489-54-1 3-(3-{[Benzenesulfonyl-(4-pyrazol-1-yl-benzyl)-amino]-methyl}-phenyl)-propionic acid 
• 223490-98-0 3-(3-{[benzenesulfonyl-(4-pyrazol-1-yl-benzyl)-amino]-methyl}-phenyl)-propionic acid methyl ester 
• 223491-45-0 3-(3-{[benzenesulfonyl-(4-pyrazol-1-yl-benzyl)-amino]-methyl}-phenyl)-2-methyl-propionic acid methyl ester 
• 223489-64-3 3-(3-{[(1-Methyl-1H-imidazole-4-sulfonyl)-(4-pyrazol-1-yl-benzyl)-amino]-methyl}-phenyl)-propionic acid 
• 223492-61-3 3-(3-{[(4-Pyrazin-2-yl-benzyl)-(thiazole-2-sulfonyl)-amino]-methyl}-phenyl)-propionic acid methyl ester 
• 223490-86-6 3-(3-{[benzenesulfonyl-(4-pyrazin-2-yl-benzyl)-amino]-methyl}-phenyl)-propionic acid methyl ester 

Relevant articles and documents

PYRROLIDINE DERIVATIVES AS TRYPTASE INHIBITORS

Compounds of a certain formula 1 in which M, B1, B2, R2, K1 and K2 have the meanings indicated in the description are novel effective tryptase inhibitors.

Prostaglandin agonists and their use to treat bone disorders

This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.